Donald K Zettervall

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
OBJECTIVE This clinical review guides consultant pharmacists on how best to integrate a range of parameters, such as glycosylated hemoglobin (A1C) levels, patient comorbidities, and quality of life issues specific to seniors, and drug risks and benefits, when determining optimal therapeutic decisions for elderly patients with type 2 diabetes mellitus(More)
OBJECTIVES Current management of hypoglycemic risk among seniors with type 2 diabetes mellitus (T2DM) is frequently not very effective. Treatment guidelines with target glycosylated hemoglobin (A1C) levels provide important standards for T2DM management, but target goals must be determined on an individual basis in conjunction with individual factors,(More)
  • 1